Novartis Ag (NVS) Operating Leases (2019 - 2025)

Novartis Ag (NVS) has 7 years of Operating Leases data on file, last reported at $1.7 billion in Q4 2025.

• Quarterly Operating Leases rose 3625.53% year-over-year to $1.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 3625.53% YoY) and the FY2025 annual result came in at $1.7 billion, up 3625.53% from the prior year.
• Operating Leases rose to $1.7 billion in Q4 2025 per NVS's latest filing, from -$47.0 million in the prior quarter.
• The five-year high for Operating Leases was $1.9 billion in Q4 2021, with the low at -$47.0 million in Q4 2024.
• Average Operating Leases over 5 years is $399.3 million, with a median of -$12.0 million recorded in 2022.
• Year-over-year, Operating Leases jumped 4409.09% in 2021 and plunged 132.19% in 2024.
• Novartis Ag's Operating Leases stood at $1.9 billion in 2021, then slumped by 98.79% to $23.0 million in 2022, then jumped by 534.78% to $146.0 million in 2023, then sank by 132.19% to -$47.0 million in 2024, then jumped by 3625.53% to $1.7 billion in 2025.
• Business Quant data shows NVS's Operating Leases at $1.7 billion in Q4 2025, -$47.0 million in Q4 2024, and -$45.0 million in Q3 2024.